| abstract |
The invention relates to the field of immunology, more specifically to adjuvants used to increase the immunogenicity of antigens, for example, for incorporation into vaccines. The invention provides use of a pulmonary surfactant or a component thereof as an adjuvant substance that is able to stimulate an immune response, but, in general, are homologous to substances native to the body. |